Pfizer was founded in 1849 by Charles Pfizer and Charles Erhart with the driving ambition to discover innovations that help people. Over the past 175 years, we have achieved that and so much more. To date, we’ve reached billions of patients with our medicines and vaccines. Throughout our history, Pfizer has transformed from a small Brooklyn, New York founded family business to a global force for good, delivering breakthroughs that have helped to change billions of patient lives. Pfizer’s innovation has driven the company to strive to meet national and global challenges. From the company’s treatments during the Civil War and the mass production of penicillin during World War II to Pfizer’s current suite of modern medicines, our innovative spirit has been felt across generations. Perhaps no recent breakthrough has been more vital than Pfizer’s role in developing the first vaccine and oral treatment in response to the COVID-19 pandemic. These are just a few examples of Pfizer’s legacy of delivering impactful medicines and vaccines, demonstrating the company’s unwavering dedication to innovation. In 2023, the company invested $10.7 billion in internal R&D projects, which we believe is a testament to Pfizer’s commitment to delivering the next wave of pipeline innovation.
Today, Pfizer is ignited by a renewed focus on oncology and delivering impactful medicines that change patients’ lives. Pfizer was founded with the dream to deliver medicines and vaccines that would have positive impacts on global health. Nearly two centuries later, Pfizer has been at the forefront of medical and pharmaceutical breakthroughs that have not only helped to change patient lives, but shaped history. Looking ahead, we believe Pfizer’s expertise, technology and innovation will continue to drive the company forward as we strive to deliver the next generation of breakthroughs for the world’s most pressing health challenges.
